PrimeRFP SCOUT · Federal Contract Recompete Brief

19AQMM26P0604NARCAN NASAL SPRAY devices — Emergent Devices, Inc

Emergent Devices, Inc holds $753K across 16 federal awards, concentrated at Department of Homeland Security (DHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Jun 1, 2027 PoP end — agencies typically plan 12–18 months ahead.

Acquisitions - Aqm Momentum

Awarding office

Emergent Devices, Inc

Recipient

Jun 1, 2027

PoP end

$285K

Obligated

$285K

Potential

541990

NAICS

R408

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Emergent Devices, Inc — $90

Contract facts

NONE

Contract number19AQMM26P0604

Also listed as19AQMM-26-P-0604

AgencyAcquisitions - Aqm Momentum

Awarding officeAcquisitions - Aqm Momentum

Awarding agencyDepartment of State (DOS)

Funding agencyDepartment of State (DOS)

IncumbentEmergent Devices, Inc

CAGE7ARJ9

UEIQ1MZNNSQUJ53

NAICS541990

No full NAICS 541990 intel page yet. Browse NAICS intelligence

PSCR408

Pricing typeFirm Fixed Price

Extent competedNot Competed

Related solicitation19AQMM21Q0113

PoP startJun 2, 2026

PoP end (current)Jun 1, 2027

Obligated$285K

Current value$285K

Potential value$285K

NARCAN NASAL SPRAY DEVICES is a federal NONE award for Acquisitions - Aqm Momentum held by Emergent Devices, Inc. Estimated value $285K ($285K obligated). Current period of performance ends Jun 1, 2027. Last award drew 1 bidder. Related solicitation 19AQMM21Q0113.

Recompete timing

Public

● Expiring in 284 days

Current PoP ends Jun 1, 2027 (284 days remaining). Agencies typically plan 12–18 months ahead — at 9.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Emergent Devices, Inc — $753K obligated across 16 awards (firm-wide, all agencies) · lead buyer Department of Homeland Security (DHS).

% of firm-wide obligated ($753K) · all agencies

Department of Homeland Security (DHS)$473K · 63%Department of State (DOS)$285K · 38%

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 19AQMM26P0604?

19AQMM26P0604 (NARCAN NASAL SPRAY devices) is a Acquisitions - Aqm Momentum award with a potential value of $285K, currently held by Emergent Devices, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 19AQMM-26-P-0604?

19AQMM-26-P-0604 is the dashed form of PIID 19AQMM26P0604 (NARCAN NASAL SPRAY devices), held by Emergent Devices, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 19AQMM26P0604?

Acquisitions - Aqm Momentum awarded 19AQMM26P0604 to Emergent Devices, Inc (potential $285K).

Who is the incumbent on 19AQMM26P0604?

Emergent Devices, Inc is the incumbent with $753K across 16 related awards in SCOUT’s public footprint. The current period of performance ends Jun 1, 2027.

When does Emergent Devices, Inc’s 19AQMM26P0604 come up for recompete?

SCOUT tracks a period-of-performance end of Jun 1, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jul 1, 2026 · refreshed monthlyLatest procurement action Jun 2, 2026